With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that grants BIOVECTRA access to Revolution Biomanufacturing's proprietary platforms ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

Researchers showed that an mRNA influenza vaccine delivered with their new lipid nanoparticle could generate the same immune ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Study finds protein traits and CHO-cell gene programs drive therapeutic protein yields, guiding biomanufacturing.

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.